Mihir Pharma Llp - Due diligence report

A 360° intelligence report on Mihir Pharma Llp: trust score, financial health, credit view, compliance, directors, growth and distress signa…

2015-09-04 Pune, Maharashtra Active
Share
View plans
MP Mihir Pharma Llp
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹349 50% off New user
Or enjoy up to 50% off with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Mihir Pharma Llp — 360° Intelligence Report

Generated from MCA filings & public records
71/100
Trust Score
Moderate

Mihir Pharma Llp is assessed as Moderate with a Trust Score of 71/100. Mihir Pharma Llp is an active limited liability partnership incorporated in 2015, operating in the Pharma sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a low compliance risk and high financial risk profile.

Report generated on 28 Jun 2026 from the latest processed filings. Mihir Pharma Llp snapshot & full profile →

Financial Health › Weak
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
71/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
75/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
35/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
55/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreNo Data
N/A
Needs at least two filed years to measure growth.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 1 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 55/100 Moderate

    Charges position: 1 open (2.00 Lakh) · 0 satisfied (-).

    Banking relationships (from registered charges)
    LenderChargesAmount
    Idbi Bank Limited1 48.0 cr
    Compliance Score: 75/100 Low Risk
    • Company status is Active as per MCA.
    • Last balance sheet is for Mar 2017 - filings overdue.
    05

    Director Intelligence

    Stability score: 95/100
    NameDIN / PANDesignationAppointedTenureDIN status
    VASANTI SUDHAKAR RAUT 01234567 Director 01/04/2018 6 yrs Approved
    SUDHAKAR GOVIND RAUT 01234567 Director 01/04/2018 6 yrs Approved
    • 2 directors on the board.
    • No disqualified or deactivated DINs.
    • Stable board - no exits in 3 years.
    • Average tenure above 5 years.
    06

    Ownership & Group Intelligence

    Promoter holding
    64.27%
    Public / other holding
    35.73%
    Equity shares
    12,45,67,890
    Equity paid-up
    124.5 cr
    Promoters on record
    4
    Ultimate holding entity
    -
    Subsidiaries
    -
    Group entities
    -
    Capital events
    -

    Full shareholding pattern, group structure & capital events →

    07

    Risk Intelligence Center

    Growth N/A · Distress 80
    Growth signals & trust indicators
    Operating for 10+ years.
    Distress signals & risk flags
    Statutory filings appear overdue.
    1 open charge(s) registered - assets are encumbered.
    08

    Stakeholder Verdicts

    Vendor · Banker · Investor
    Vendor due diligence75/100
    Favourable indicators
    Suitability as a supplier / customer counterparty.
    • Statutory record is clean.
    • 1 distress signal(s) - see Risk Center.
    • Financial filings available for verification.
    Banker assessment54/100
    Mixed indicators - deeper appraisal suggested
    Indicative lending comfort for banks, NBFCs and trade credit.
    • Debt capacity assessed from filed statements.
    • 1 open charge(s) of 2.00 Lakh already registered.
    • Compliance record supports lending.
    Investor view30/100
    Limited indicators at present
    Growth quality and scalability through an investor lens.
    • No clear growth signals in the filed years.
    • Margin and return trends computable from filings.
    • Management team looks stable.
    09

    MCA Filings & Events Timeline

    Latest 7 events
    31 Mar 2018
    Last AGM held
    Annual general meeting
    31 Mar 2017
    Latest balance sheet
    Filed with ROC
    21 Sep 2016
    Charge created
    Idbi Bank Limited - 2.00 Lakh
    30 Sep 2015
    Director appointed
    VASANTI SUDHAKAR RAUT (Designated Partner)
    29 Sep 2015
    Director ceased
    GIRISH GOVINDRAO KAKDE
    04 Sep 2015
    Incorporated
    Registered with Roc Pune
    Director appointed
    SUDHAKAR GOVIND RAUT (Designated Partner)
    10

    Key Observations

    Auto-generated from the data above
    Compliance record is strong - status, filings and flags are clean.
    2 active director(s) / partner(s); board looks stable and experienced.
    11

    Peers & Related Companies

    Full peer comparison →
    CompanyCINLocation
    Akshar Pharma Private Limited U51397MH2002PTC135935 Mumbai, Maharashtra, India
    Northern Institute Of Neuro Sciences Private Limited U85110CH2005PTC028386 Chandigarh, Chandigarh, India
    Anvit Pharma Private Limited U24248TG2013PTC085771 Hyderabad, Telangana, India
    Decibells Pharmaceuticals Private Limited U74899DL2002PTC114558 N Delhi, Delhi, India
    Amptech Pharmaceutical Private Limited U85100WB2009PTC136250 Howrah, West Bengal, India
    Onemed Crew Private Limited U74900PB2014PTC038646 Mohali, Punjab, India
    Avani Pharma Private Limited U51397KA2011PTC058775 Bangalore, Karnataka, India
    Chanchal Medicare Private Limited U24100MP2015PTC034470 Indore, Madhya Pradesh, India
    12

    Who Uses This Report

    CA · CS · Banker · Investor · Vendor
    Chartered Accountants (CA)

    Verify Mihir Pharma Llp before audits and certifications: compliance score 75/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

    Company Secretaries (CS)

    Track statutory health of Mihir Pharma Llp: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

    Bankers & NBFCs

    Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 55/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

    Investors & Analysts

    Investor view: Limited indicators at present. Growth score n/a, margin trends, ownership structure and peer set for Mihir Pharma Llp - screening before a deeper diligence.

    Vendors & Procurement Teams

    Vendor verdict: Favourable indicators. Trust score 71/100, distress signals and MSME payment-delay disclosures - know whether Mihir Pharma Llp pays its suppliers before you extend credit terms.

    Lawyers & Compliance Teams

    Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Mihir Pharma Llp - groundwork for KYC, onboarding and disputes.

    13

    Frequently Asked Questions

    Is Mihir Pharma Llp an active company?

    Mihir Pharma Llp has MCA status “Active” with a compliance score of 75/100 (Low Risk).

    Is Mihir Pharma Llp financially healthy?

    Mihir Pharma Llp has a Financial Health Score of 35/100 (Caution Indicated) based on its filed financial statements.

    Should I do business with Mihir Pharma Llp?

    Its overall Trust Score is 71/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

    Who controls Mihir Pharma Llp?

    See the directors and ownership sections above for board and shareholding detail. 2 active director(s) are on record.

    Does Mihir Pharma Llp have loans or charges against its assets?

    1 open charge(s) are registered against its assets.

    Is Mihir Pharma Llp up to date with its ROC filings?

    Last balance sheet is for Mar 2017 - filings overdue. Overall compliance score: 75/100 (Low Risk).

    Is it risky to lend to Mihir Pharma Llp?

    Its Credit Risk Score is 55/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

    Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.